Long non-coding RNAs (lncRNAs) play key roles in the regulation of breast cancer initiation
and progression. LncRNAs are differentially expressed in breast cancer subtypes. Basal-like …

Accumulating evidence highlights the potential role of long non-coding RNAs (lncRNAs) as
biomarkers and therapeutic targets in solid tumors. However, the role of lncRNA expression …

Evidence is emerging that long noncoding RNAs (lncRNAs) may play a role in cancer
development, but this role is not yet clear. We performed a genome-wide transcriptional …

Background Luminal subtype breast cancer accounts for a predominant number of breast
cancers. Considering the heterogeneity of the disease, it is urgent to develop novel …

Breast cancer is the second leading cause of cancer related deaths in women. It is therefore
important to understand the mechanisms underlying breast cancer development as well as …

Background Recent genome-wide profiling by sequencing and distinctive chromatin
signatures has identified thousands of long non-coding RNA (lncRNA) species (> 200 nt) …

Long non‐coding RNAs (lncRNAs) are acknowledged as regulators of cancer biology and
pathology. Our goal was to perform a stringent profiling of breast cancer cell lines that …

Breast cancer is a heterogeneous disease that arises as a multi-stage process involving
multiple cell types. Patients diagnosed with the same clinical stage and pathological …

Long non-coding RNAs (lncRNAs) are involved in breast cancer pathogenesis through
chromatin remodeling, transcriptional and post-transcriptional gene regulation. We report …

Breast cancer is the most commonly diagnosed neoplasm in women worldwide with a well-
recognized heterogeneous pathology, classified into four molecular subtypes: Luminal A …